Skip to main content

Table 1 Baseline demographic characteristics

From: Understanding the risk factors for adverse events during exchange transfusion in neonatal hyperbilirubinemia using explainable artificial intelligence

Characteristic

Value

Total ET count

188

Male sex

112(59.6%)

Gestational age (weeks)

37.93 ± 1.63

Premature

34 (18.1%)

Delivery by C-section

66(35.1%)

Apgar score

9.88 ± 0.48

Birth weight (g)

3201.30 ± 429.75

Weight at admission (g)

3036.97 ± 430.53

Age at admission (days)

6.42 ± 3.97

Length of stay

9.31 ± 3.93

Etiology

Unidentified

96(51.1%)

ABO incompatibility

65(34.6%)

G6PD deficiency

30(16.0%)

Rh incompatibility

21 (11.2%)

MN incompatibility

1 (0.5%)

Other diagnosis

Bilirubin encephalopathy

63 (33.5%)

Sepsis

22(11.7%)

Anemia

15 (8%)

Necrotizing enterocolitis

2(1.1%)

Purulent meningitis

2(1.1%)

Exchange transfusion (ET)

ET volume (ml)

495.27 ± 78.59

ET time (minutes)

96.77 ± 18.82

TSB before ET

388.70 ± 107.66

TSB during ET

253.41 ± 80.29

TSB after ET

198.75 ± 62.13

TSB 1 day after ET

220.60 ± 58.95

Bilirubin exchange rate

0.48 ± 0.10

Adverse events during ET

Hyperglycemia

162(86.2%)

Requiring top-up transfusion after ET

95(50.5%)

Hypocalcemia

80(42.6%)

Hyponatremia

80(42.6%)

Thrombocytopenia

72(38.3%)

Metabolic acidosis

48(25.5%)

Hypokalemia

48(25.5%)

Hyperkalemia

6(3.2%)

Convulsion

5(2.7%)

Cyanosis

5(2.7%)